A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain
Clinical trial NCT03213457 · COMPLETED
Trial details
- NCT number
- NCT03213457
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-07
- Primary completion
- 2020-03-27
- Enrollment
- 681
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.